OICR Official Calls for More Investment in Canadian Personalized Medicine

In an online commentary in CMAJ, an OICR official argues that if Canada's support of personalized medicine can't compete with other regions, the country will lose commercialization opportunities.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories